{"nct_id":"NCT04721015","title":"Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2021-02-23","start_date_type":"ACTUAL","primary_completion_date":"2026-02","primary_completion_date_type":"ESTIMATED","completion_date":"2026-02","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["ABBV"]}